Australia markets closed

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.5200+0.1000 (+2.92%)
At close: 04:00PM EDT
3.5500 +0.03 (+0.85%)
After hours: 06:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
153,731
153,731
67,772
61,880
42,722
Operating expenses
Research development
180,425
180,425
137,171
104,400
76,961
Selling general and administrative
62,584
62,584
59,544
56,004
36,818
Total operating expenses
243,009
243,009
196,715
160,404
113,779
Operating income or loss
-89,278
-89,278
-128,943
-98,524
-71,057
Interest expense
23,750
23,750
3,346
3,137
3,974
Total other income/expenses net
9,917
9,917
12,130
-4,454
41,498
Income before tax
-88,601
-88,601
-116,704
-105,538
-32,025
Income tax expense
18,192
18,192
2,500
0
103
Income from continuing operations
-106,793
-106,793
-119,204
-105,538
-32,128
Net income
-106,793
-106,793
-119,204
-105,538
-32,128
Net income available to common shareholders
-106,793
-106,793
-119,204
-105,538
-32,128
Basic EPS
-2.91
-1.78
-2.35
-2.29
-0.99
Diluted EPS
-2.91
-1.78
-2.35
-2.29
-0.99
Basic average shares
59,193
60,164
50,739
46,119
32,573
Diluted average shares
59,193
60,164
50,739
46,119
32,573